title: HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells.
abstract: Treatment resistant latent reservoirs remain a barrier to cure HIV, but the maintenance and properties of these reservoirs are not completely understood. 2-LTR circular HIV DNA has been used to assess ongoing viral replication in HAART treated patients. However, the half-life of this DNA form is still debated with conflicting in vivo and in vitro data. Prior in vitro studies have focused on cell lines or short lived activated cells in cultures of brief duration, while in vivo studies have the added complications of cell migration, division, and death. Therefore, we monitored the stability of 2-LTR circles in primary CD4+T cells in a month long culture and compared it to the stability of integrated HIV DNA and T cell receptor excision circles (TRECs), another circular DNA form that is thought to be stable. We found that 2-LTRs, along with TRECs, were stable, suggesting 2-LTRs do not necessarily indicate ongoing replication.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Pennsylvania, 422 Curie Blvd, 702 Stellar Chance,. Philadelphia, PA 19104, USA.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Pace
authors.forename: Erin H
authors.initials: EH
authors.lastname: Graf
authors.forename: Una
authors.initials: U
authors.lastname: O'Doherty
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000821:virology*; D002478:Cells, Cultured; D004270:DNA, Circular / Q000235:genetics*; D004279:DNA, Viral / Q000235:genetics*; D042822:Genomic Instability; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015498:HIV-2 / Q000235:genetics*; D006801:Humans; D013997:Time Factors
chemical_list: D004270:DNA, Circular; D004279:DNA, Viral
references.citation: AIDS Rev. 2011 Apr-Jun;13(2):63-6
references.pmid: 21587339
references.citation: Nature. 1998 Dec 17;396(6712):690-5
references.pmid: 9872319
references.citation: J Infect Dis. 2008 Feb 1;197(3):411-9
references.pmid: 18248304
references.citation: Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):517-24
references.pmid: 21971333
references.citation: J Virol. 2002 Apr;76(8):3739-47
references.pmid: 11907213
references.citation: Nature. 1997 May 8;387(6629):183-8
references.pmid: 9144289
references.citation: PLoS Pathog. 2012;8(7):e1002818
references.pmid: 22911005
references.citation: Nat Med. 2010 Apr;16(4):460-5
references.pmid: 20228817
references.citation: Nat Med. 2000 Jan;6(1):76-81
references.pmid: 10613828
references.citation: PLoS One. 2011;6(6):e21081
references.pmid: 21687638
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3879-84
references.pmid: 18332425
references.citation: PLoS Pathog. 2011 Feb;7(2):e1001300
references.pmid: 21383972
references.citation: Viral Immunol. 2005;18(1):190-6
references.pmid: 15802963
references.citation: J Virol. 2005 Apr;79(8):5203-10
references.pmid: 15795303
references.citation: AIDS. 2003 Mar 28;17(5):645-52
references.pmid: 12646786
references.citation: J Virol. 2002 Apr;76(8):4138-44
references.pmid: 11907256
references.citation: J Mol Med (Berl). 2001 Nov;79(11):631-40
references.pmid: 11715066
references.citation: AIDS. 2012 Mar 13;26(5):543-50
references.pmid: 22410637
references.citation: Immunity. 2012 Feb 24;36(2):288-97
references.pmid: 22365666
references.citation: Nat Rev Microbiol. 2009 Nov;7(11):798-812
references.pmid: 19834480
references.citation: Nat Med. 1999 May;5(5):512-7
references.pmid: 10229227
references.citation: Immunity. 1999 May;10(5):569-75
references.pmid: 10367902
references.citation: Blood. 2009 Mar 26;113(13):2999-3007
references.pmid: 19008454
references.citation: Mol Cell Biol. 1996 Feb;16(2):609-18
references.pmid: 8552089